The purpose of the 2023 evaluation of the Genebank Platform is to support the institutional learning of Crop Trust and CGIAR and provide evidence regarding the efficiency and effectiveness of the Genebank Platform (from 2017-21). The evaluation exercise aims to also identify good practices and lessons for the Genebanks Initiative and Genetic Innovation Science Group and CGIAR at large.
Towards evaluation credibility, data collection will follow a mixed methods design, leveraging both qualitative and quantitative data from primary and secondary sources to answer evaluation questions, understand operating environments and track contextual and programmatic assumptions.
Eight key evaluation questions are framed along the five evaluation criteria: relevance, effectiveness, efficiency, coherence and added-value, and sustainability and learning for impact (see CGIAR-wide Evaluation Policy).
The data collection would incorporate semi-structured interviews, in-depth document and literature reviews, field visit(s) to Genebanks and strategically identified gatherings of Platform stakeholders for face-to-face interactions. Accordingly, three platform module studies, two deep dive studies and an exploratory social network analysis will be developed as the core source of evidence for developing evaluation conclusions and recommendations.
All Genebank Platform stakeholders are welcome and encouraged to engage in the evaluation process, participate in interviews and respond to the forthcoming survey. Please contact IAES-Evaluation@cgiar.org for related inquiries.
CGIAR Independent Advisory and Evaluation Service (IAES). (2023). Evaluation of the CGIAR Genebank Platform: Inception Report. Rome: IAES Evaluation Function. https://iaes.cgiar.org/evaluation
Independent Advisory and Evaluation Service (IAES)